Skip to main content
Published at: 

Ecraid introduces new COO Nils Visser

Utrecht, 10 May 2022 – The Ecraid Management Board is pleased to announce the appointment of Nils Visser as its new Chief Operations Officer (COO). With effect from 1 June 2022, Nils will be responsible for the development and execution of Ecraid’s operational planning and strategy. 
 
Nils has over 10 years’ experience in Clinical Trial execution and joined University Medical Center Utrecht (UMCU) in 2020 as Manager of Clinic Operations in the COVID-19 trial unit. He progressively took on new roles and challenges within the UMCU’s European Project Group, including leading role in the Group’s transition to Ecraid. Prior to this, Nils was Operations Director at Semiotic Labs, a start-up where he managed all operational aspects from supply chain strategy to project management and quality.
 
Nils brings with him more than 35 years of proven industry and professional experience in international environments. His strong track record in project management, operational excellence and change management will contribute to our mission to tackle infectious diseases by joining forces and creating the highest quality clinical evidence.

“I am honoured for the opportunity and look forward to help execute on Ecraid’s mission to develop innovative clinical trial concepts that will advance the fight against infectious diseases. By working closely with industry and academia, we have high chances to respond faster and more effectively to clinical outbreaks and advance our fight against infectious diseases,” says Nils.

In his new role, Nils will be a part of Ecraid’s management board and responsible for business planning and control, operational execution, quality and risk management, IT strategy development, and business support functions along with sustaining operational relations.

Ecraid CEO Marc Bonten says, “Nils has made invaluable contributions to our organisation, and I have no doubt that as COO, he will help implement strategic vision and values of Ecraid Foundation, and drive growth.”

Please join us in congratulating Nils on his new leadership role at Ecraid Foundation.
 
 
About Ecraid
 
The European Clinical Research Alliance for Infectious Diseases (Ecraid) is a not-for profit foundation that advances clinical research in the field of infectious diseases by establishing a long-term, financially self-sustainable, clinical research network in Europe. Headquartered in Utrecht, the Netherlands, Ecraid is the first network of its kind in Europe to offer a single point of access to a pan-European clinical research network for infectious diseases and spans 1,100 clinical sites and 900 laboratories across 42 countries. For more information, please visit www.ecraid.eu.
 
For more information, please contact:
 
Ecraid Press Office
Daniele Pazzola, Communications Manager
Email: daniele.pazzola@uantwerpen.be
Tel: +32 476 74 28 68